- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 235
Pro.com fixes up $33m series B
The home renovation software developer has raised $33m in a round co-led by Redfin, Goldman Sachs and WestRiver, taking its total funding to more than $50m.
Jan 21, 2019ScaleFactor to grow with $30m series B
The Citi Ventures-backed bookkeeping software provider has increased its total funding to almost $43m in a Bessemer Venture Partners-led round.
Jan 21, 2019Innovaccer gets $35m funding injection
Microsoft’s M12 subsidiary led an extension that brought Innovaccer’s series B round to a $35m close, and the company’s overall funding to $51m.
Jan 21, 2019HyperScience hits series B round with $30m
QBE and TD Ameritrade have taken part in a series B round that will be used to develop the company's artificial intelligence-based data entry technology.
Jan 21, 2019Corporate venturing deal net: 14-18 January 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Jan 18, 2019Wiliot picks up $30m signal
The bluetooth tag maker is now valued at $120m following a series B round featuring Qualcomm Ventures, Merck Group, Amazon, Samsung Ventures and Avery Dennison.
Jan 16, 2019Measurabl builds out series B round
The real estate data management platform has closed an $18.7m round following commitments from Berman Enterprises, DivcoWest, Exelon and S&P Global.
Jan 16, 2019Lambda School passes $30m exam
The computer science academy has raised series B funding at a $150m valuation from investors including GV, three months after closing its series A round.
Jan 14, 2019Beta Bionics bets on corporates in $63m round
Zealand and Dexom has contributed to a $13m extension to the artificial pancreas developer's series B round, which also includes Novo Nordisk.
Jan 14, 2019Biond Biologics forms corporate bonds to raise $17m
Celgene has taken part in a Harel Insurance Finance-led series B round that will fund the progress of Biond's lead immuno-oncology drug into clinical trials.
Jan 14, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


